Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL28097092 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL28220547 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL8673096 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL28212538 | 0.89 | — | — | |
| Sulfuric Acid SCHEMBL481202 | 0.88 | ALDH1A1 (0.60) | — | |
| Sulfuric Acid SCHEMBL7891773 | 0.88 | ALDH1A1 (0.60) | — | |
| Sulfuric Acid SCHEMBL8732464 | 0.88 | ALDH1A1 (0.60) | — | |
| Sulfuric Acid SCHEMBL29132022 | 0.88 | ALDH1A1 (0.60) | — | |
| Sulfuric Acid SCHEMBL29020604 | 0.88 | ALDH1A1 (0.60) | — | |
| Sulfuric Acid SCHEMBL11430373 | 0.88 | ALDH1A1 (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3765465-A1 | CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | Bayer Aktiengesellschaft (DE) | 2021-01-20 | — | — | EP | disclosed |
| WO-2019175045-A1 | CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2019-09-19 | — | — | WO | disclosed |
| EP-2074118-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | AstraZeneca AB (SE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009007748-A2 | TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | ASTRAZENECA AB (SE) | 2009-01-15 | — | — | WO | disclosed |